Seed · AI & Machine Learning · Warsaw, Poland · Founded 2016 · 25–50 employees
Molecule.one is a Polish AI-driven pharmaceutical company that uses deep learning to predict chemical synthesis pathways and accelerate drug discovery. The startup combines AI-powered retrosynthesis modeling with a fully automated high-throughput lab that can conduct over 20,000 reactions per week. They recently won $1 million in Standard Industries' Chemical Innovation Challenge and have formed strategic partnerships with companies like W.R. Grace and CAS. The company has raised $4.6 million in funding and is building what they call the first commercially available chemical synthesis planning software entirely based on deep learning models.
No open roles listed right now.